Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Anti-Cancer Drugs|June 13, 1998
Phase II study with cisplatin and paclitaxel in combination with weekly high-dose 24 h infusional 5-fluorouracil/leucovorin for first-line treatment of metastatic breast cancerU Klaassen, H Wilke, R Weyhofen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancerA Welt, G von Minckwitz, C Oberhoff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
Paclitaxel in combination with weekly 24-hour infusional 5-fluorouracil plus leucovorin in the second-line treatment of metastatic breast cancer: results of a phase II studyU Klaassen, H Wilke, A Harstrick, et al.
British Journal of Cancer|December 22, 1999
Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell linesU Vanhoefer, M R Müller, R A Hilger, et al.
Anti-Cancer Drugs|October 17, 1998
Comparison between short or long exposure to 5-fluorouracil in human gastric and colon cancer cell lines: biochemical mechanism of resistanceA Harstrick, A Gonzales, N Schleucher, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagusM Stahl, H Wilke, H J Meyer, et al.
Cancer|October 1, 1993
Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancerC Schöber, E Papageorgiou, A Harstrick, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinomaA Harstrick, H J Schmoll, C Bokemeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II studyA Harstrick, H J Schmoll, H Wilke, et al.
Seminars in Oncology|December 1, 1994
The role of granulocyte-macrophage colony-stimulating factor in the treatment of germ cell tumors. German Testicular Cancer Study GroupC Bokemeyer, A Harstrick, U Rüther, et al.
Pageof 9